Daily non-political popular news in brief.

Web-based program could ease treatment decisions for prostate cancer patients

05-15-2007 · EurekAlert!

A Web-based program that provides prostate cancer patients with information about different treatment approaches may make deciding which path to follow a little easier, Medical College of Georgia researchers say.

Keywords: web-based, program, ease, treatment, decisions, prostate, cancer, patients, web, based, decision, patient

« Previous | Next »

Similar news on "Web-based program could ease treatment decisions for prostate cancer patients":

UCLA study finds prostate cancer treatments impact on quality of life
04-23-2007 · EurekAlert!
A rigorous, long-term study of quality of life in patients who underwent one of the three most common treatments for prostate cancer found that each affected men's lives in different ways. The findings provide invaluable information for men with prostate cancer who are facing vital treatment decisions.
Similar news · Read more »
Family counseling improves lives of patients and spouses coping with prostate cancer
11-12-2007 · EurekAlert!
Families coping with prostate cancer report improved quality of life from a structured support program integrated into the patient's cancer management, according to a new study.
Similar news · Read more »
Pre-treatment blood test could guide lung cancer therapy
06-05-2007 · EurekAlert!
A multi-center team, led by Vanderbilt-Ingram Cancer Center investigators, has developed a new pre-treatment blood test that predicts which non-small-cell lung cancer patients will live longer when they are treated with certain targeted cancer therapies (Iressa, Tarceva). The mass spectrometry-based test, described in the June 6 Journal of the National Cancer Institute, may allow physicians to select the most beneficial therapy for each lung cancer patient, a step forward in the era of personalized medicine.
Similar news · Read more »
'Mismatched' prostate cancer treatment more common than expected
11-26-2007 · EurekAlert!
More than a third of men with early prostate cancer who participated in a study analyzing treatment choice received therapies that might not be appropriate, based on pre-existing problems with urinary, bowel or sexual function. The prevalence of these treatment "mismatches" could reflect patient unwillingness to discuss such problems with their physicians.
Similar news · Read more »
Computer predicts wishes of incapacitated patients better than family or loved ones
03-12-2007 · EurekAlert!
When a person fails to complete an advance directive and becomes incapacitated by illness or injury, doctors typically ask the patient's loved one to predict what treatment the patient would have wanted. But a paper in PLoS Medicine reports that a computer-based decision tool can predict a patient's treatment wishes better than a loved one.
Similar news · Read more »
OHSU Cancer Institute researchers get closer to predict survivability for some cancer patients
06-27-2007 · EurekAlert!
Oregon Health & Science University Cancer Instituteresearchers have developed a Web-based software program that can helphead and neck cancer patients better predict their survivability.
Similar news · Read more »
Nonhormonal drug reduces hot flashes in men treated for prostate cancer
06-03-2007 · EurekAlert!
North Central Cancer Treatment Group researchers based at Mayo Clinic in Rochester, Minn., have discovered that low doses of a drug used to prevent epileptic seizures and to treat nerve pain caused by shingles substantially reduces hot flashes in patients who are undergoing anti-hormonal treatment, or androgen-deprivation therapy, for prostate cancer.
Similar news · Read more »
A drug's brand name skews patient treatment choices
05-21-2007 · EurekAlert!
The brand name of a drug can strongly influence treatment decisions by patients, according to a randomized trial of decision aids by researchers from McMaster University.
Similar news · Read more »
Custom-made cancer cell attacks
02-16-2007 · EurekAlert!
Imagine a cancer treatment tailored to the cells in a patient’s body, each person receiving a unique treatment program. This is what Natural Sciences and Engineering Research Council grantee Thomas Ruth and his colleagues hope to accomplish within the next decade. Using the TRIUMF particle accelerator based in Vancouver, British Columbia, they are taking vast amounts of radioactive material and separating the particular atoms they need for therapy
Similar news · Read more »
Phase II study shows HRPC patients with bone metastases see improved survival with ZD4054
09-25-2007 · EurekAlert!
New Phase II data presented today suggest that ZD4054, a novel compound in development for the treatment of men with hormone-resistant prostate cancer, could offer a promising improvement in overall survival in men with metastatic HRPC who were asymptomatic or mildly symptomatic for pain.1 Patients who received ZD4054 10mg once-daily experienced a 45 percent reduction in the risk of death compared to placebo.
Similar news · Read more »